Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
about
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKRetrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004-2013) using administrative data.An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis.Review of cryptogenic fibrosing alveolitis, including current treatment guidelinesRecent advances in the aetiology of cryptogenic fibrosing alveolitis.Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database.Capsaicin induced cough in cryptogenic fibrosing alveolitis.British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.Accuracy of mortality data for interstitial lung diseases in New Mexico, USAUpdate in diffuse parenchymal lung disease 2006.Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease.Epidemiology of idiopathic pulmonary fibrosis.Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century.The burden of lung disease.The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis.Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit.Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders.Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK.
P2860
Q24670477-002034AC-A4E8-4178-BBA5-9E0494907FD0Q31161630-8B2F411E-1E85-4414-8464-9C631AB39AE0Q33714184-91948D6A-8677-4908-9624-6A32394CE1E0Q33785553-BB99AC9B-1723-409F-9B3C-AC22AC193A82Q34048271-3BC90C64-F922-47DC-ABFA-0823F0645DD5Q34105545-C886D9C6-10B7-4030-8B13-F8513321F495Q35533436-EBACB7DA-F1D2-426E-B65A-5098DCE582E7Q35533585-B55C3EBA-7BC4-4700-BFD3-92152262F32BQ35563129-C1FFA80A-19AB-43F5-9693-DCC38BD28F7EQ35913543-8AD3E2EF-6906-4859-8997-A9033C66D8C7Q36496362-4BBCDB89-82DC-4A54-8CB6-AA3F52D50FFDQ36769703-E93F5A74-C364-4916-B6D7-40A0A607C2CBQ37133224-1B25BADC-150A-47FC-8DDD-46A4102F6682Q37359126-49DD147B-0C03-49ED-B34B-D64267902B4BQ39138520-BDDCDF56-08AD-484D-A965-33247DF3DA04Q42743927-FA561CCC-E507-4127-8563-5F95E8CF4A88Q43872514-4C6401DB-A03E-4AC3-AAB3-B8B338288ED4Q50900397-A6F2F620-8B6D-477C-BBE6-85DA2B66F220Q51704008-D3902763-9A32-4002-A6DC-0D932846E899Q53888201-0888F26B-A379-42A1-87B4-9873D1B743EEQ55021008-B2D8F42D-5C3F-463F-B5DA-5193821FB8C7
P2860
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
@ast
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
@en
type
label
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
@ast
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
@en
prefLabel
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
@ast
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
@en
P2093
P2860
P356
P1433
P1476
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
@en
P2093
D B Coultas
I Johnston
P2860
P304
P356
10.1136/THX.51.7.711
P407
P577
1996-07-01T00:00:00Z